Conygar Investment Company (LON: CIC) is selling its 203-acre brownfield land at Rhosgoch in Anglesey to Rhosgoch Property, a subsidiary of Stena Lin. The net proceeds will be £18.3m, compared with a valuation of £2.5m. NAV was £63.8m (107.5p/share) at the end of March 2025, but since then there has been a £750,000 loss on the sale of a Virgin Active gym. The share price increased 19.6% to 30.5p.
Light Science Technologies (LON: LST) has won an AgTech contract worth £500,000. It will design and supply a modular vertical farming system for the Nottingham Trent University Smart Agricultural Research Centre. This includes nurturGROW lighting, sensorGROW sensors and Tomtech control technologies. These products will be manufactured by the contact electronics subsidiary. The share price rose 8.47% to 6.4p.
Synthetic DNA products developer 4basebio (LON: 4BB) says a global pharma partner has begun dosing patients with an mRNA product developed with 4basebio’s opDNA template. The share price improved 6.9% to 775p.
One Health Group (LON: OHGR) has made a strong start to the year. Surgical procedures jumped 16% and interim revenues were 17% higher at £15.5m, which is 10% higher than forecast. EBITDA is expected to be higher than the previous year and Panmure Liberum anticipates a figure of more than £1m. Cash is £10.8m. There have been delays in building the surgical hub, but it should still be open by the end of 2026. There is normally a second half boost from the NHS demand when it is trying to reduce waiting lists. Changes in administration provide uncertainty, though. That is why the full year pre-tax profit forecast of £2.3m is unchanged. The share price gained 6.79% to 236p.
FALLERS
Monoclonal antibodies developer Bioventix (LON: BVXP) reported a dip in revenues from £13.6m to £13.1m, while pre-tax profit slipped 6% to £10.2m. There was pricing pressure in China, where revenues declined 29% to £2.4m. The newer Alzheimer’s-related portfolio quadrupled revenues. Further declines in revenues and profit are expected this year. The share price slid 18.3% to 1900p
Great Western Mining Corporation (LON: GWMO) says soil sampling at the Huntoon copper project in Nevada shows elevated levels of tungsten, copper and zinc. The soil geochemical anomaly has been extended to more than 2.8km. The consistency of anomalies suggests a larger than anticipated mineralised system. Further analysis will help to design a new drilling campaign. The share price fell 7.69% to 1.8p.
Landore Resources (LON: LND) is raising £1.47m at 4.125p/share. The cash will be spent on the BAM gold project at the Junior Lake property in Ontario, Canada. An updated mineral resource estimate is due to be published. The share price declined 7.61% to 4.25p.
First Development Resources (LON: FDR) has raised £1m in an oversubscribed placing at 3p/share. Each share comes with a warrant exercisable at 5p each. The cash will be used to speed up exploration at the Selta project and focus on rare earth targets at Ingallan and Nintabrinna West. There will also be exploration for gold in another part of the project area. There will also be limited spending on the Wallal gold copper prospect. The share price dipped 6.15% to 3.05p.